SavedAdd your journal

Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2013 / Cilt: 47 - Sayı: 3

Vitiligo related to autoimmüne polyglandular syndrome: Type 3B-3C

Vitiligo ileilişkili otoimmün poliglandüler sendrom: TİP 3B+C

Bülent YAŞAR
Şirin YAŞAR
Zehra SERDAR AŞİRAN
Yeşim SABUNCUOĞLU DOĞAN
Pages
183–186
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report a case of APS-3B-3C in a 32-year-old man with generalized autoimmüne thyroiditis associated with vitiligo and autoimmüne gastritis. (Turkderm 2013; 47: 183-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitiligo is a relatively common skin disease characterised by development of patchy depigmented macules.
📊
Key Findings & Data:Although etiopathogenesis of vitiligo, which progresses with melanocyte destruction, is not exactly known.
💡
Conclusion & Impact:We report a case of APS-3B-3C in a 32-year-old man with generalized autoimmüne thyroiditis associated with vitiligo and autoimmüne gastritis. (Turkderm 2013; 47: 183-6)
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Vitiligo is a relatively common skin disease characterised by development of patchy depigmented macules. Although etiopathogenesis of vitiligo, which progresses with melanocyte destruction, is not exactly known. İt is usually based on the autoimmün hypothesis. We report a case of APS-3B-3C in a 32-year-old man with generalized autoimmüne thyroiditis associated with vitiligo and autoimmüne gastritis. (Turkderm 2013; 47: 183-6)

Özet

Vitiligo, sık rastlanılan, melanosit kaybı ile giden depigmente maküllerle karakterize bir deri hastalığıdır. Etyopatogenezi tam olarak bilinmemekle birlikte otoimmün hipotez üzerinde durulmaktadır. Burada otoimmün tiroidit, vitiligo ve otoimmün gastritin bir arada olduğu OPS-3B+C olarak değerlendirilen 32 yaşındaki bir erkek olgu bildirilmiştir. (Türk­derm 2013; 47: 183-6)

🔖

Cite This Article

YAŞAR, B., YAŞAR, Ş., AŞİRAN, Z. S., DOĞAN, Y. S. (2022). Vitiligo related to autoimmüne polyglandular syndrome: Type 3B-3C. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 47 - Sayı: 3, 183–186. https://ajindex.com/articles/621874

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Njoo MD, Westerhof W: Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001;2:167-81.
  2. Amerio P, Tracanna M, De Remigis P, et al: Vitiligo associated with other autoimmüne diseases: polyglandular autoimmüne syndrome types 3B+C and 4. Clin Exp Dermatol 2006;31:746-9.
  3. Gauthier Y, Cario Andre M, Taïeb A: A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003;16:322-32.
  4. Betterle C, Zanchetta R: Update on autoimmüne polyendocrine syndromes (APS). Acta Biomed 2003;74:9-33.
  5. Betterle C, Lazzarotto F, Presotto F: Autoimmüne polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immünol 2004;137:225-33.
  6. Betterle C, Dal Pra C, Mantero F, Zanchetta R: Autoimmüne adrenal insufficiency and autoimmüne polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327-64.
  7. Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP: Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 1998;139:798-805.
  8. Turkoglu Z, Kavala M, Kolcak O, Zindanci I, Can B: Autoimmüne polyglandular syndrome-3C in a child. Dermatol Online J 2010;16:8. Orozco-Topete R, Córdova-López J, Yamamoto-Furusho JK, et al: HHLA- DRB1 *04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmüne thyroid disease. J Am Acad Dermatol 2005;52:182-3.
  9. Mason CP, Gawkrodger DJ: Vitiligo presentation in adults. Clin Exp Dermatol 2005;30:344-5.
  10. Amerio P, Di Rollo D, Carbone A, et al: Polyglandular autoimmüne diseases in a dermatological clinical setting: vitiligo-associated autoimmüne diseases. Eur J Dermatol. 2010;20:354-8.
  11. Neufeld M, Maclaren NK, Blizzard RM: Two types of autoimmüne Addison's disease associated with different polyglandular autoimmüne (PGA) syndromes. Medicine (Baltimore) 1981;60:355-62.
  12. Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C: Type 1 diabetes and autoimmüne polyglandular syndrome: a clinical review. Neth J Med 2009;67:376-87.